RE:RE:Updates that matterAgree very much with what you are saying. But, recognize that Getinge continues to keep a gag on TSO3's ability to express consumables and installs, as the actual installs and sales are, by agreement, Getinge's business, and only, so they maintain, indirectly our business, leaving us with data only on sales to Getinge which have already been telegraphed by Rumble. Take, for example, the complete lack of news out of TSO3 on the EU rollout. I saw a series adverts on Linked In, etc. in January for at least 9 sales positions with Getinge for the EU, including G. Britain (where prion disease is a huge public health issue more than scopes!), France, Sweden, and even Turkey and Dubai! These were for sale people exclusively to promote the new low temperature options that Getinge offers. Management at TSO3 only hints that the roll-out is going according to plan, or better, with units being delivered; but, Getinge, (due to not wanting to show their hand to the competition?) just as in the case of the US makes, no concrete statements. I suspect Getinge's EU organization is significantly better organized than the N. American branches. I fully anticipate RR and GK will add significant colour to the entry of the VP4 into the European market, at least in response to questions; but, I wish they would put out descrete PR's (with Getinge's blessing?) so that we are not left in the dark. Further updates on the ongoing prion testing in France(?) will also be significant, as, if the VP4 can eliminate prions this will be another revolutionary game changer and will put TSO3's products even further out front of the fading competition. And, of course, the state of the new FDA submission will be extremely important.
Just my thoughts... WKH